Insider Selling: Rocket Pharmaceuticals (NASDAQ:RCKT) General Counsel Sells $11,806.34 in Stock
MarketBeat
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) General Counsel Martin Wilson sold 3,493 shares of the firm's stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $3.38, for a total value of $11,806.34. Following the completion of the sale, the general counsel owned 674,484 shares in the company, valued at $2,279,755.92. The trade was a 0.52% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
NASDAQ:RCKT